Gilboa Therapeutics vs Moderna
Gilboa Therapeutics vs Moderna, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Gilboa Therapeutics is on 43/100 and Moderna on 77/100.
Where each one leads
Gilboa Therapeutics
Leads on none of the measures we hold for both companies.
Moderna
- our overall score: 77/100 against 43/100
- agent readiness: 49/100 against 22/100
- domain rating: 79/100 against 4/100
- headcount: 6,297 against 2
- LinkedIn following: 780,086 against 956
At a glance
| Measure | Gilboa Therapeutics | Moderna |
|---|---|---|
| What it is | Preclinical biopharma developing next-gen cancer immunotherapies using proprietary SolidT technology. | Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics. |
| Category | Biopharmaceuticals, Immunotherapy, Cancer Treatment, Biotechnology | Biotechnology, mRNA Technology, Vaccines, Pharmaceuticals |
| Sells toBusiness model | B2G | B2B |
| Offering | Hardware | Services |
| Founded | 2017 | 2010 |
| Headquarters | Tel Aviv, Israel | Cambridge, United States |
| Status | Inactive | Active |
Size, funding and growth
| Measure | Gilboa Therapeutics | Moderna |
|---|---|---|
| Employees | 2 | 6,297 |
| Headcount growthLast 12 months | -49.5% | Not published |
| Open roles | Not published | 100 |
| Total funding | Not published | $4.5B |
| Latest round | Not published | Funding Round |
| LinkedIn followers | 956 | 780,086 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Gilboa Therapeutics | Moderna |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 43/100 | 77/100 |
| Traction | 11/100 | 60/100 |
| Team | Not published | 70/100 |
| Community | Not published | 13/100 |
| Search visibility | 54/100 | 46/100 |
| Quality | Not published | 90/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (22/100) | D (49/100) |
| Domain ratingLink authority, 0-100 | 4/100 | 79/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Gilboa Therapeutics | Moderna |
|---|---|---|
| Hosting | Not detected | AWS |
| CDN | Not detected | CloudFront |
| Frameworks | Not detected | Next.js |
What users say
| Measure | Gilboa Therapeutics | Moderna |
|---|---|---|
| Community ratingVisitor votes on StartupHub | Not published | 2.0/5 from 1 vote |
Gilboa Therapeutics vs Moderna: common questions
Which is better, Gilboa Therapeutics or Moderna?
On our 0-100 score Moderna rates higher (77/100 against 43/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do Gilboa Therapeutics and Moderna compare on the numbers?
Moderna leads on our overall score (77/100 against 43/100), agent readiness (49/100 against 22/100), domain rating (79/100 against 4/100), headcount (6,297 against 2), LinkedIn following (780,086 against 956).
Read the full Gilboa Therapeutics review and pricing or the Moderna review and pricing. You can also browse other Gilboa Therapeutics alternatives we track.